Clinical Trial Update: Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of Alpha-1 MP (human alpha-1 proteinase inhibitor, modified process) in pulmonary emphysema due to alpha-1 antit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Pulmonary Emphysema

Drugs mentioned

• Alpha-1 MP (Alpha-1 Proteinase Inhibitor, Human, Modified Process) (alpha-1 proteinase inhibitor (human), modified process)

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Pulmonary Emphysema in Alpha-1 PI Deficiency | Phase 3 | Status: ACTIVE_NOT_RECRUITING